ChEVAS for Abdominal Aortic Aneurysm
(ChEVAS One Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new treatment called the Chimney Endovascular Aortic Sealing (ChEVAS) System for individuals with complex abdominal aortic aneurysms (AAA), which are dangerous bulges in the main blood vessel in the stomach area. The trial aims to determine how effectively this system can repair these aneurysms without open surgery, using a special type of stent (a tube that keeps vessels open). Individuals with a large or rapidly growing abdominal aortic aneurysm might be suitable candidates for this trial. Those affected by such an aneurysm that impacts daily life might consider participating. As an unphased trial, this study provides an opportunity to explore innovative treatment options that could enhance quality of life.
Do I need to stop my current medications for the trial?
The trial information does not specify if you need to stop taking your current medications. However, if you have a known allergy or contraindication to any device material, contrast, or anticoagulants, you may not be eligible to participate.
What prior data suggests that the ChEVAS System is safe for endovascular repair of complex abdominal aortic aneurysms?
Studies have shown that the Chimney Endovascular Aortic Sealing (ChEVAS) System is generally safe for treating complex abdominal aortic aneurysms. One study confirmed over seven years that this technique is both safe and effective. Another study found that high-risk patients tolerate the procedure well, with acceptable outcomes.
While these studies suggest ChEVAS is safe, individual experiences can vary. Reports indicate some risks, including illness and death, similar to those of other procedures.
Overall, research supports the safety of ChEVAS. However, as with any medical procedure, discussing potential risks and benefits with a healthcare provider is advisable.12345Why are researchers excited about this trial?
The ChEVAS System is unique because it combines the Nellix System with parallel branch chimney stents to treat abdominal aortic aneurysms near the kidneys or other major abdominal organs. Unlike traditional open surgery or standard endovascular aneurysm repair (EVAR), which may not effectively manage complex aneurysms close to vital arteries, ChEVAS offers a minimally invasive approach that promises better compatibility with these challenging cases. Researchers are excited about this treatment because it could expand the range of patients eligible for less invasive procedures and potentially improve outcomes by sealing the aneurysm more reliably while preserving blood flow to vital organs.
What evidence suggests that the ChEVAS System is effective for abdominal aortic aneurysms?
Studies have shown that the Chimney Endovascular Aortic Sealing (ChEVAS) System, which participants in this trial will receive, provides good long-term results for patients with complex abdominal aortic aneurysms. It has successfully treated high-risk patients, demonstrating positive outcomes over time. Research indicates that the ChEVAS procedure uses special tubes, called stents, to seal aneurysms and help prevent them from bursting. In simpler terms, it helps stop the blood vessel from breaking open, which poses a serious risk. Early findings suggest that this treatment holds promise for complicated cases.12567
Are You a Good Fit for This Trial?
This trial is for adults over 18 with abdominal aortic aneurysms meeting specific size criteria and without significant vessel angulation. Candidates must consent to follow-up visits, not be in other studies within the last 30 days, have no allergies to materials used, or conditions like Marfan Syndrome that could affect results.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-procedure Imaging
Participants undergo a high resolution, contrast-enhanced CT scan of the relevant aortic and aortoiliac vasculature within three months of the scheduled procedure
Treatment
The ChEVAS procedure involves the use of the Nellix System in conjunction with parallel branch chimney stents for the treatment of abdominal aortic aneurysms
Follow-up
Participants are monitored for safety and effectiveness after treatment with follow-up visits at 30-days, 6-months, and annually to 5-years
What Are the Treatments Tested in This Trial?
Interventions
- Chimney Endovascular Aortic Sealing (ChEVAS) System
Find a Clinic Near You
Who Is Running the Clinical Trial?
Endologix
Lead Sponsor